Huang Jiabing, Chen Pengfei, Hu Xinqun, Tang Jianjun, Fang Zhenfei
Department of Cardiovascular Medicine, The Second Xiangya Hospital of Central South University, Changsha, China.
Medicine (Baltimore). 2018 Aug;97(33):e11900. doi: 10.1097/MD.0000000000011900.
Cardiogenic shock secondary to aortic stenosis (AS) is a challenging problem owing to the high mortality associated with treatment, and successful treatment of such patients has been rare.
A 77-year-old man presented with exercise intolerance and progressive exertional dyspnea and chest pain. The patient was suffered from cardiogenic shock after percutaneous coronary intervention.
He was diagnosed by transthoracic echocardiography (TTE) and coronary angiogram. His main diagnose was AS and coronary artery disease.
The patient received venoarterial extracorporeal membrane oxygenation (VA-ECMO) and transcatheter aortic valve replacement (TAVR).
As of the 5-month follow-up, the patient was well, and capable of basic independent living. The TTE suggested that the left ventricular end-diastolic volume had decreased from 66 to 45 mm and the left ventricular ejection fraction had risen from 20% to 50%.
Patients with cardiogenic shock secondary to AS are very difficult to treat medically. ECMO with TAVR may be a reasonable strategy.
继发于主动脉瓣狭窄(AS)的心源性休克是一个具有挑战性的问题,因为治疗相关死亡率很高,且成功治疗此类患者的情况很少见。
一名77岁男性出现运动不耐受、进行性劳力性呼吸困难和胸痛。该患者在经皮冠状动脉介入治疗后发生心源性休克。
通过经胸超声心动图(TTE)和冠状动脉造影进行诊断。其主要诊断为AS和冠状动脉疾病。
患者接受了静脉-动脉体外膜肺氧合(VA-ECMO)和经导管主动脉瓣置换术(TAVR)。
截至5个月的随访,患者情况良好,能够基本独立生活。TTE显示左心室舒张末期容积从66毫米降至45毫米,左心室射血分数从20%升至50%。
继发于AS的心源性休克患者药物治疗非常困难。ECMO联合TAVR可能是一种合理的策略。